undamentalytics Newsletter

Warmuth Michael J: insider trades

Officer at Abbott Laboratories. No open-market purchases and 16 sales not made under a pre-set plan, reported from February 18, 2010 to March 2, 2017.

What happened after Warmuth Michael J’s sales?

After their sales, the shares moved +2.5% against the index over 12 months on average (a negative figure means selling was the right call); 44% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Warmuth Michael J: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 16 −0.2% 0.0% 50% 8 −0.14 0.89 No reliable evidence
Sales, 12 months after the report 16 +2.5% +6.4% 44% 8 0.42 0.69 No reliable evidence
Sales, 12 months after the trade 16 +2.5% +5.0% 38% 8 0.40 0.70 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Abbott Laboratories ABT Executive Vice President016February 18, 2010March 2, 2017

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 2, 2017March 1, 2017 ABT Sale $174,797 +0.5%+19.9%+17.9%
July 27, 2016July 26, 2016 ABT Sale $1,165,457 −8.6%−1.9%+2.0%
March 2, 2016February 29, 2016 ABT Sale $365,123 −3.7%−2.4%−5.5%
March 12, 2015March 10, 2015 ABT Sale $626,571 +1.9%−12.1%−12.3%
March 4, 2014March 3, 2014 ABT Sale $642,952 −2.9%+7.6%+6.0%
January 31, 2014January 29, 2014 ABT Sale $413,880 +0.3%+10.8%+12.9%
February 20, 2013February 19, 2013 ABT Sale $106,635 −0.3%−9.4%−8.5%
August 17, 2012August 16, 2012 ABT Sale $624,854 −1.7%−7.3%−8.2%
April 3, 2012March 30, 2012 ABT Sale $815,569 +7.9%+13.2%+15.0%
March 2, 2012March 1, 2012 ABT Sale $1,047,356 +11.9%+13.1%+15.1%
December 23, 2011December 21, 2011 ABT Sale $789,965 −1.9%+5.2%+4.8%
June 3, 2011June 1, 2011 ABT Sale $691,035 +9.2%+20.3%+21.5%
March 2, 2011February 28, 2011 ABT Sale $54,167 +7.9%+18.0%+17.5%
November 10, 2010November 9, 2010 ABT Sale $559,717 −17.6%+8.2%+5.2%
April 27, 2010April 26, 2010 ABT Sale $513,132 +5.5%−8.3%−6.7%
February 18, 2010February 16, 2010 ABT Sale $54,600 −11.0%−34.9%−36.7%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Warmuth Michael J traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.